Baldrige Asset Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
$5K Sell
192
-7
-4% -$188 ﹤0.01% 289
2022
Q4
$6K Buy
199
+73
+58% +$1.87K ﹤0.01% 266
2022
Q3
$3K Hold
126
﹤0.01% 277
2022
Q2
$4K Hold
126
﹤0.01% 275
2022
Q1
$4K Hold
126
﹤0.01% 286
2021
Q4
$4K Sell
126
-4
-3% -$130 ﹤0.01% 296
2021
Q3
$4K Sell
130
-4
-3% -$128 ﹤0.01% 322
2021
Q2
$4K Buy
+134
New +$4.41K ﹤0.01% 323

Other funds holding OGN

Baldrige Asset Management's OGN Position: Q1 2023 in Review

Baldrige Asset Management reduced its Organon & Co (OGN) stake by 3.5% in Q1 2023, selling an estimated $188 and leaving 192 shares worth $5K. The position accounts for ﹤0.01% of the portfolio, ranked #289.

Baldrige Asset Management first reported a position in OGN in Q2 2021 and has held it in 8 quarters since. The position peaked at $6K in Q4 2022. 767 funds tracked by Wall St. Rank hold OGN as of Q1 2023.

  • Baldrige Asset Management held 192 shares of Organon & Co worth $5K as of Q1 2023.
  • Baldrige Asset Management sold 7 Organon & Co shares in Q1 2023, an estimated $188.
  • Organon & Co made up ﹤0.01% of Baldrige Asset Management's portfolio in Q1 2023, its #289 holding.
  • Baldrige Asset Management first reported a position in Organon & Co in Q2 2021 and has held it in 8 quarters since.
  • Baldrige Asset Management's Organon & Co position peaked at $6K in Q4 2022.
  • 767 funds tracked by Wall St. Rank held Organon & Co as of Q1 2023.

Based on Baldrige Asset Management's 13F filing for Q1 2023, filed 17 Apr 2023.